The estimated Net Worth of Justin J. Lampropoulos is at least $3.87 Million dollars as of 12 March 2021. Mr. Lampropoulos owns over 25,000 units of Merit Medical Systems stock worth over $2,656,372 and over the last 9 years he sold MMSI stock worth over $0. In addition, he makes $1,211,600 as Executive Vice President - Sales and Marketing and Strategy at Merit Medical Systems.
Justin has made over 4 trades of the Merit Medical Systems stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 25,000 units of MMSI stock worth $405,750 on 12 March 2021.
The largest trade he's ever made was exercising 25,000 units of Merit Medical Systems stock on 12 March 2021 worth over $405,750. On average, Justin trades about 5,583 units every 84 days since 2016. As of 12 March 2021 he still owns at least 27,343 units of Merit Medical Systems stock.
You can see the complete history of Mr. Lampropoulos stock trades at the bottom of the page.
Justin J. Lampropoulos serves as Executive Vice President - Sales, Marketing and Strategy of the Company. Education: Completed postgraduate studies at Oxford University's Saïd Business School in Oxford, England in strategic management and is an alumnus of Harvard Business School. Mr. Justin J. Lampropoulos is the son of Fred P. Lampropoulos, Merit’s Chair of the Board, President and CEO. Highlights. From 2010 to 2015 led Merit’s Europe, Middle East and Africa business unit from Maastricht, the Netherlands. Began his career in the medical device technology field in 2004.
As the Executive Vice President - Sales and Marketing and Strategy of Merit Medical Systems, the total compensation of Justin Lampropoulos at Merit Medical Systems is $1,211,600. There are 4 executives at Merit Medical Systems getting paid more, with Fred Lampropoulos having the highest compensation of $5,049,290.
Justin Lampropoulos is 37, he's been the Executive Vice President - Sales and Marketing and Strategy of Merit Medical Systems since 2015. There are 16 older and no younger executives at Merit Medical Systems. The oldest executive at Merit Medical Systems, Inc. is A. Scott Anderson, 73, who is the Independent Director.
Justin's mailing address filed with the SEC is 1600 WEST MERIT PARKWAY, , SOUTH JORDAN, UT, 84095.
Over the last 24 years, insiders at Merit Medical Systems have traded over $17,410,674 worth of Merit Medical Systems stock and bought 12,774 units worth $365,476 . The most active insiders traders include Fred P Lampropoulos, Kent W Stanger, and A Scott Anderson. On average, Merit Medical Systems executives and independent directors trade stock every 24 days with the average trade being worth of $1,968,745. The most recent stock trade was executed by F. Ann Millner on 28 June 2024, trading 12,500 units of MMSI stock currently worth $631,250.
merit medical systems, inc. (nasdaq: mmsi) is a leading manufacturer of medical devices used in diagnostic & interventional cardiology & radiology procedures. its primary products consist of inflation devices used in angioplasty, stent placement & discography; diagnostic & therapeutic catheters used for various procedures in cardiology & radiology; guide wires used to place balloon angioplasty catheters within a patient's coronary arteries; products used to manage & monitor the administration of contrast & other fluid solutions during diagnostic & therapeutic procedures; thrombolytic catheters & fluid dispensing systems; angiography accessories; & standard & custom angiography kits. headquartered in south jordan, utah, a suburb of salt lake city, merit employs approximately 1,900 people worldwide. merit markets its products in the united states & europe (direct sales force) & the world (distributors). they call directly on physicians & clinicians in hospitals & clinics worldwide. the c
Merit Medical Systems executives and other stock owners filed with the SEC include: